STOCK TITAN

Column Group discloses 11.6% Eikon Therapeutics stake after IPO (EIKN)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

The Column Group investment entities and principals have disclosed a large ownership position in Eikon Therapeutics, Inc. common stock. Together, they report beneficial ownership of 6,353,712 shares, representing 11.6% of Eikon’s outstanding common stock.

The stake is held through multiple venture funds and includes shares underlying warrants exercisable within 60 days. The position stems from preferred stock investments made between 2019 and 2025 that converted into common stock at Eikon’s initial public offering, plus additional common shares purchased in the IPO at $18 per share.

The investors describe their holdings as for general investment purposes and may increase or decrease their position over time. They also hold registration rights under an investors’ rights agreement and have agreed to 180-day lock-up restrictions following the IPO underwriting agreement.

Positive

  • None.

Negative

  • None.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 4,312,139 shares of Common Stock held of record by TCG IV LP (as defined in Item 2(a) below) and (ii) 148,840 shares of Common Stock held of record by TCG IV-A LP (as defined in Item 2(a) below). TCG IV GP LP (as defined in Item 2(a) below) is the general partner of each of TCG IV LP and TCG IV-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported by the Issuer in its prospectus filed with the Securities and Exchange Commission on February 5, 2026 (the Prospectus).


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of 4,312,139 shares of Common Stock held of record by TCG IV LP. TCG IV GP LP is the general partner of TCG IV LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of 148,840 shares of Common Stock held of record by TCG IV-A LP. TCG IV GP LP is the general partner of TCG IV-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 1,319,164 shares of Common Stock held of record by TCG Opportunity III LP (as defined in Item 2(a)) and (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement. TCG Opportunity III GP LP (as defined in Item 2(a)) is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LLC (as defined in Item 2(a)) is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP LLC and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 54,557,906 shares of Common Stock, which is the sum of (i) 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus, plus (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 1,319,164 shares of Common Stock held of record by TCG Opportunity III LP and (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement. TCG Opportunity III GP LP is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP LLC and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 54,557,906 shares of Common Stock, which is the sum of (i) 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus, plus (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 1,319,164 shares of Common Stock held of record by TCG Opportunity III LP and (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement. TCG Opportunity III GP LP is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP LLC and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 54,557,906 shares of Common Stock, which is the sum of (i) 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus, plus (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 4,312,139 shares of Common Stock held of record by TCG IV LP, (ii) 148,840 shares of Common Stock held of record by TCG IV-A LP, (iii) 1,319,164 shares of Common Stock held of record by TCG Opportunity III LP and (iv) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement. TCG IV GP LP is the general partner of each of TCG IV LP and TCG IV-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LP is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP LLC and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 54,557,906 shares of Common Stock, which is the sum of (i) 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus, plus (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 4,312,139 shares of Common Stock held of record by TCG IV LP, (ii) 148,840 shares of Common Stock held of record by TCG IV-A LP, (iii) 1,319,164 shares of Common Stock held of record by TCG Opportunity III LP and (iv) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement. TCG IV GP LP is the general partner of each of TCG IV LP and TCG IV-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LP is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP LLC and may each be deemed to share voting, investment and dispositive power with respect to these securities. This calculation is based upon 54,557,906 shares of Common Stock, which is the sum of (i) 53,984,337 shares of Common Stock outstanding (assuming the underwriters do not exercise their option to purchase additional shares) as reported in the Prospectus, plus (ii) 573,569 shares underlying warrants to purchase shares of Common Stock held by TCG Opportunity III LP which are exercisable within 60 days of this Statement.


SCHEDULE 13D


The Column Group IV GP, LP
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
The Column Group IV, LP
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
The Column Group IV-A, LP
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
The Column Group Opportunity III, LP
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
The Column Group Opportunity III GP, LP
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
TCG Opportunity III GP, LLC
Signature:/s/ James Evangelista
Name/Title:James Evangelista, Attorney-in-Fact
Date:02/12/2026
Tim Kutzkey
Signature:/s/ James Evangelista
Name/Title:James Evangelista, as Attorney-in-Fact for Tim Kutzkey
Date:02/12/2026
Peter Svennilson
Signature:/s/ James Evangelista
Name/Title:James Evangelista, as Attorney-in-Fact for Peter Svennilson
Date:02/12/2026

FAQ

What does the Schedule 13D filing reveal about Eikon Therapeutics (EIKN)?

The Schedule 13D shows that Column Group-affiliated funds and principals hold a significant stake in Eikon Therapeutics. They collectively report beneficial ownership of 6,353,712 common shares, or 11.6% of the company, reflecting years of preferred investments converted at the IPO plus IPO share purchases.

How many Eikon Therapeutics (EIKN) shares do Column Group entities beneficially own?

Column Group-related reporting persons beneficially own 6,353,712 shares of Eikon Therapeutics common stock. This represents 11.6% of the outstanding common shares, including stock held by several Column Group funds and shares underlying warrants exercisable within 60 days of the statement.

How did Column Group build its position in Eikon Therapeutics (EIKN)?

Column Group funds invested in multiple Eikon preferred rounds from 2019 to 2025, then converted those preferred shares into common stock at the IPO. They also bought additional common shares in the IPO at $18.00 per share, further increasing their ownership stake.

What percentage of Eikon Therapeutics (EIKN) does each Column Group fund hold?

TCG IV LP holds 4,312,139 shares (8.0%), TCG IV-A LP holds 148,840 shares (0.3%), and TCG Opportunity III LP-related entities hold 1,892,733 shares (3.5%). Tim Kutzkey and Peter Svennilson each report aggregate beneficial ownership of 6,353,712 shares, or 11.6% of Eikon’s common stock.

Are Column Group’s Eikon Therapeutics (EIKN) shares subject to lock-up restrictions?

Yes. The reporting persons entered lock-up agreements in connection with Eikon’s IPO. They agreed, subject to specified exceptions, not to sell, transfer, or otherwise convey their Eikon securities for 180 days following the date of the IPO underwriting agreement.

What are Column Group’s stated intentions for its Eikon Therapeutics (EIKN) investment?

The filing states the securities are held for general investment purposes. Depending on market conditions, Eikon’s business, and other factors, the reporting persons may buy more shares, sell some or all holdings, or consider further investments or dispositions over time.
Eikon Therapeutics

NASDAQ:EIKN

View EIKN Stock Overview

EIKN Rankings

EIKN Latest News

EIKN Latest SEC Filings

EIKN Stock Data

568.46M
17.65M
Biotechnology
Healthcare
Link
United States
Millbrae